**Question:** The mechanism of anti-cancer action of fluorouracil is:

A. Inhibition of thymidylate synthase (TS)
B. Inhibition of pyrimidine biosynthesis
C. Inhibition of DNA polymerase
D. Inhibition of ribonucleotide reductase

**Core Concept:**
Fluorouracil (5-FU) is an antimetabolite chemotherapeutic agent used in cancer treatment. Its mechanism of action relates to the inhibition of essential enzymes involved in pyrimidine synthesis and DNA repair in rapidly dividing cancer cells. The primary target is dihydropyrimidine dehydrogenase (DPD), which is responsible for the initial step in the degradation of fluorouracil.

**Why the Correct Answer is Right:**
Fluorouracil is primarily eliminated by DPD, an enzyme that degrades the drug into its active form, 5-fluorodeoxyuridine monophosphate (FdUMP), which further inhibits thymidylate synthase (TS), an enzyme involved in the synthesis of thymidylate, a precursor of deoxythymidine monophosphate (dTMP), a crucial component of DNA synthesis. Inhibition of TS leads to decreased DNA synthesis and replication, ultimately resulting in cell death and cancer cell suppression.

**Why Each Wrong Option is Incorrect:**

A. Inhibition of thymidylate synthase (TS) is correct but not the only mechanism of action of fluorouracil. Inhibition of other enzymes, like DNA polymerase or ribonucleotide reductase, could be relevant in other contexts.

B. This option describes the inhibition of pyrimidine biosynthesis, which is partially correct but doesn't capture the complete mechanism of action. The primary target of fluorouracil is DPD, not pyrimidine biosynthesis.

C. DNA polymerase inhibition is not the primary mechanism of action for fluorouracil. While some inhibition of DNA polymerase might occur, the primary target is DPD and subsequent inhibition of TS.

**Clinical Pearl:**
Fluorouracil is used in combination with other chemotherapeutic agents like leucovorin (folinic acid) to counteract the toxicity caused by DPD inhibition and improve the therapeutic ratio of the drug. This combination is commonly used in the treatment of colon, breast, and head and neck cancers.